Empagliflozin + Linagliptin in pharma franchise in Telangana

Empagliflozin + Linagliptin in PCD pharma franchise in Raipur

Empagliflozin + Linagliptin in top pharma company in Bhopal

Empagliflozin + Linagliptin in pcd pharma supplier in Visakhapatnam

Empagliflozin + Linagliptin in phama franchise company in India
Empagliflozin + Linagliptin in phama distributor in Pimpri-Chinchwad

Emplozin L 10/5 Tablet

Composition : Empagliflozin (10mg) + Linagliptin (5mg)

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Emplozin L 10/5 Tablet is a combination therapy containing Empagliflozin (10mg) and Linagliptin (5mg), designed to provide effective management of type 2 diabetes mellitus. This combination works through complementary mechanisms to help control blood sugar levels and improve overall glycemic control in diabetic patients.

  • Empagliflozin, a SGLT2 inhibitor, works by preventing the reabsorption of glucose in the kidneys, leading to its excretion through urine. This reduces blood sugar levels and also supports weight loss and a reduction in blood pressure.
  • Linagliptin, a DPP-4 inhibitor, increases insulin secretion and decreases glucagon secretion in response to meals. This results in improved control of blood glucose levels without causing significant hypoglycemia.

Together, these two drugs target different pathways to manage type 2 diabetes, providing a balanced and effective solution for maintaining blood sugar levels within a healthy range.

Read More

About the Product

Emplozin L 10/5 Tablet is a combination therapy containing Empagliflozin (10mg) and Linagliptin (5mg), designed to provide effective management of type 2 diabetes mellitus. This combination works through complementary mechanisms to help control blood sugar levels and improve overall glycemic control in diabetic patients.

  • Empagliflozin, a SGLT2 inhibitor, works by preventing the reabsorption of glucose in the kidneys, leading to its excretion through urine. This reduces blood sugar levels and also supports weight loss and a reduction in blood pressure.
  • Linagliptin, a DPP-4 inhibitor, increases insulin secretion and decreases glucagon secretion in response to meals. This results in improved control of blood glucose levels without causing significant hypoglycemia.

Together, these two drugs target different pathways to manage type 2 diabetes, providing a balanced and effective solution for maintaining blood sugar levels within a healthy range.

Common side effects may include nasopharyngitis, headache, urinary tract infections, and gastrointestinal disturbances. Serious side effects can include dehydration, hypotension, or kidney problems.

Emplozin L 10/5 Tablet is indicated for the management of type 2 diabetes mellitus to improve glycemic control, especially in patients who are unable to achieve adequate control through diet, exercise, and other medications alone.

Consult your doctor before using if you have a history of kidney problems or urinary tract infections. Do not use if pregnant or breastfeeding.

Store in a cool, dry place at room temperature (15°C-30°C), away from light and moisture.

Get in Touch